Molecular and Integrative Physiological Effects of Isoflurane Anesthesia: The Paradigm of Cardiovascular Studies in Rodents using Magnetic Resonance Imaging

Frontiers in Cardiovascular Medicine

Volumn 3, Issue , 2016, Pages

  Constantinides, Christakis ^a,b   Murphy, Kathy ^b  

^a Chi Biomedical Ltd   (Cyprus)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

anesthesia; cardiac function; inotropy; isoflurane; lusitropy; magnetic resonance imaging; nitrous oxide; rodents

Indexed keywords

EID: 85011278903     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2016.00023     Document Type: Review

References (115)

1. Janssen BJA, Celle TD, Debets J, Brouns A, Callahan M, Smith T. Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol (2004) 287:H1618–24.10.1152/ajpheart.01192.200315155266
2. Lugli AK, Yost CS, Kindler CH. Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia. Eur J Anaesthesiol (2009) 26(10):807–20.10.1097/EJA.0b013e32832d6b0f19494779
3. Forman SA, Chin VA. General anesthetics and molecular mechanisms of unconsciousness. Anesthesiol Clin (2008) 46(3):43–53.10.1097/AIA.0b013e3181755da5
4. Emmanouil DE, Quock RM. Advances in understanding the actions of nitrous oxide. Anesth Prog (2007) 54:9–18.10.2344/0003-3006(2007)54[9:AIUTAO]2.0.CO;217352529
5. Campagna JA, Miler KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med (2003) 348:2110–24.10.1056/NEJMra021261
6. Meyer HH. Welche Eigenschaft der Anasthetika bedingt ihre narkotische Wirkung? Arch Exp Pathol Pharmakol(Naunyn-Schmiedebergs) (1899) 42:109–18.10.1007/BF01834479
7. Overton E. Studien uber die Narkose. Zygleich ein Beitrag zur allgemeinen Pharmakologie. Jena, Germany: Gustav Fischer (1901).
8. A receptor. Continuing education in anesthesia. Crit Care Pain (2006) 6(2):49–53.10.1093/bjaceaccp/mki068
9. Pauling L, Marsh RE. The structure of chlorine hydrate. Proc Natl Acad Sci U S A (1952) 38:112–8.10.1073/pnas.38.2.112
10. Ebert TJ, Schmid PG, III. Inhalation anesthesia (chapter 15). 4th ed. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical Anesthesia. Philadelphia: Lippincott Williams and Wilkins (2001). p. 377–87.
11. Eger EI, Johnson BH. Rates of awakening from anesthesia with halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in eats. Anesth Analg (1987) 66:977–82.10.1213/00000539-198710000-00010
12. Lee U, Kim S, Noh GJ, Choi BM, Hwang E, Mashour GA. The directionality and functional organization of frontoparietal connectivity during consciousness and anesthesia in humans. Conscious Cogn (2009) 18:1069–78.10.1016/j.concog.2009.04.00419443244
13. Ku SW, Lee U, Noh GJ, Jun IG, Mashour GA. Preferential inhibition of frontal-to-parietal feedback connectivity is a neurophysiologic correlate of general anesthesia in surgical patients. PLoS One (2011) 6:e25155.10.1371/journal.pone.002515521998638
14. Crick F, Koch C. A framework for consciousness. Nat Neurosci (2003) 6(2):119–26.10.1038/nn0203-119
15. Mashour GA. Consciousness, anesthesia, and neural synchrony. Anesthesiology (2013) 119(1):7–9.10.1097/ALN.0b013e31828e8974
16. Schneider G, Kochs EF. The search for structures and mechanisms controlling anesthesia-induced unconsciousness. Anesthesiology (2007) 107:195–8.10.1097/01.anes.0000271869.27956.d1
17. Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, et al. Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol (2004) 21:251–6.10.1016/S0969-8051(03)00124-015013491
18. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol (2004) 65(2):443–52.10.1124/mol.65.2.44314742687
19. Franks NP. Molecular targets underlying general anaesthesia. Br J Pharmacol (2006) 147:S72–81.10.1038/sj.bjp.070644116402123
20. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci (2008) 9:370–86.10.1038/nrn237218425091
21. Franks NP. Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian γ-aminobutyric acid type A receptors. Anesthesiology (2015) 122:787–94.10.1097/ALN.000000000000058825575161
22. Maze M, Daunt DA, Salonen MU. Current research in anesthesia and trends in clinical applications (chapter 17). In: Kohn DF, Wixson SK, White WJ, Benson GJ, editors. Anesthesia and Analgesia in Laboratory Animals. London: Academic Press (1997). p. 397–404.
23. Kohro S, Hogan Q, Nakae Y, Yamakage M, Bosnjak Z. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology (2001) 95(6):1435–40.10.1097/00000542-200112000-0002411748403
24. Bertaccini EJ, Trudell JR, Franks NP. The common chemical motifs within anesthetic binding sites. Anesth Analg (2007) 104:318–24.10.1213/01.ane.0000253029.67331.8d17242087
25. Wick MJ, Mihic SH, Ueno S, Mascia MP, Trudell JR, Brozowski SJ, et al. Mutations of γ-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci U S A (1998) 95:6504–9.10.1073/pnas.95.11.6504
26. Das J, Addona GH, Sandberg WS, Husain SS, Stehle T, Miller KW. Identification of a general anesthetic binding site in the diacyglycerol-binding domain of protein kinase Cdelta. J Biol Chem (2004) 279(36):37964–72.10.1074/jbc.M405137200
27. Rottenberg H. Uncoupling of oxidative phosphorylation in rat liver mitochondria by general anesthetics. Proc Natl Acad Sci U S A (1983) 80:3313–7.10.1073/pnas.80.11.33136574486
28. Hall JE. Guyton and Hall Textbook of Medical Physiology 2011. 12th ed. Philadelphia, PA: Saunders/Elsevier (1946).
29. A, receptor/chloride channel complex in anesthesia. Anesthesiology (1993) 78:757–76.10.1097/00000542-199304000-00020
30. Hemmings HC, Jr Adamo AI. Effects of halothane and propofol in purified brain protein kinase C activation. Anesthesiology (1994) 81(1):147–55.10.1097/00000542-199407000-00021
31. 2+ transients and papillary muscle tension in guinea pigs. Anesthesiology (1992) 76:123–31.10.1097/00000542-199201000-000181729916
32. 2+ release channel of cardiac sarcoplasmic reticulum by volatile anesthetics. Anesthesiology (1994) 81(2):459–69.10.1097/00000542-199408000-000258053596
33. Hart CYT, Burnett JC, Redfield MM. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am J Physiol Heart Circ Physiol (2001) 281(5):H1938–45.11668054
34. Matsuda Y, Ohsaka K, Yamamoto H, Jiyouraku K, Natsume K, Hirabayashi S, et al. NARCOBIT: a newly developed inhalational anesthesia system for mice. Exp Anim (2007) 56:131–7.10.1538/expanim.56.13117460358
35. Ohnishi T, Pressman GS, Price HL. A possible mechanism of anesthetic-induced myocardial depression. Biochem Biophys Res Commun (1974) 57:316–22.10.1016/S0006-291X(74)80392-X
36. Pagel PS, Kampire JP, Schmeling WT, Warltier DC. Influence of volatile anesthetics on myocardial contractility in vivo: desflurane versus isoflurane. Anesthesiology (1991) 74:900–7.10.1097/00000542-199105000-000162021208
37. Price HL, Ohnishi TS. Effects of anesthetics on the heart. Fed Proc (1980) 39:1575–9.7364054
38. Szczesny G, Veihelmann A, Massberg S, Nolte D, Messmer K. Long-term anaesthesia using inhalatory isoflurane in different strains of mice: the haemodynamic effects. Lab Anim (2004) 38:64–9.10.1258/00236770460734416
39. Cornett PM, Matta JA, Ahern GP. General anesthetics sensitize the capsaicin receptor transient receptor potential V1. Mol Pharmacol (2008) 74:1261–8.10.1124/mol.108.04968418689441
40. Lambert S, Arras M, Vogt KE, Rudolph U. Isoflurane-induced surgical tolerance mediated only in part by β3-containing GABAA receptors. Eur J Pharmacol (2005) 516:23–7.10.1016/j.ejphar.2005.04.030
41. Sato Y, Seo N, Kobayashi E. Genetic background differences between FVB and C57BL/6 mice affect hypnotic susceptibility to pentobarbital, ketamine and nitrous oxide, but not isoflurane. Acta Anaesthesiol Scand (2006) 50:553–6.10.1111/j.1399-6576.2006.001002.x16643223
42. Doursout MF, Chelly JE. Effects of basal anaesthesia on cardiac function. Br J Anaesth (1998) 60:119S–22S.10.1093/bja/60.suppl_1.119S
43. Constantinides C, Mean R, Janssen BJ. Effects of isoflurane anesthesia on the cardiovascular function of the C57BL/6 mouse. ILAR J (2011) 52(3):e21–31.
44. Constantinides C, Angeli A, Mean R. Murine cardiac hemodynamics following manganese administration under isoflurane anesthesia. Ann Biomed Eng (2011) 39(11):2706–20.10.1007/s10439-011-0367-5
45. Constantinides C. Study of the murine cardiac mechanical function using magnetic resonance imaging: the current status, challenges, and future perspectives. In: Andrade AO, Alves Pereira A, Naves ELM, Soares AB, editors. Chapter 14, Practical Applications in Biomedical Engineering. Rijeka, Croatia: InTech Publications (2012) 343–86.10.5772/51364
46. Hendrich KS, Kochanek PM, Melick JA, Schiding JK, Statler KD, Williams DS, et al. Cerebral perfusion during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats studied by arterial spin-labeled MRI. Magn Reson Med (2001) 46:202–6.10.1002/mrm.117811443729
47. Wegener S, Wong EC. Longitudinal MRI studies in the isoflurane-anesthetized rat: long-term effects of a short hypoxic episode on regulation of cerebral blood flow as assessed by pulses arterial spin labelling. NMR Biomed (2008) 21:696–703.10.1002/nbm.1243
48. Crystal GJ, Zhou Z, Gurevicius J, Czinn EA, Salem MR, Alam S, et al. Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology (2000) 92:1103–13.10.1097/00000542-200004000-0002910754631
49. Ebert TJ, Stowe DF. Neural and endothelial control of the peripheral circulation – implications for anesthesia: part I. Neural control of the peripheral vasculature. J Cardiothorac Vasc Anesth (1996) 10(1):147–58.10.1016/S1053-0770(96)80190-X
50. Staunton M, Drexler C, Schmid PG, Havlik HS, Gudetz AG, Farber NE. Neuronal nitric oxide synthase mediates halothane-induced cerebral microvascular dilation. Anesthesiology (2000) 82:125–32.10.1097/00000542-200001000-0002310638908
51. Kapinya KJ, Prass K, Dirnagl U. Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? Neuroreport (2002) 13(11):1431–5.12167768
52. Woo SK, Lee TS, Kim KM, Kim JY, Jung JH, Kang JH, et al. Anesthesia condition for 18F-FDG imaging of lung metastasis tumors using small animal PET. Nucl Med Biol (2008) 35:143–50.10.1016/j.nucmedbio.2007.10.003
53. Iltis I, Kober F, Dalmasco C, Lan C, Cozzone PJ, Bernard M. In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia. J Magn Reson Imaging (2005) 22:242–7.10.1002/jmri.2035216028244
54. Hickey R, Cason B, Shubayev I. Regional vasodilating properties of isoflurane in normal swine myocardium. Anesthesiology (1994) 80:574–81.10.1097/00000542-199403000-000148141453
55. Kim Y, Heim K, Wang Y, Lees D, Myers A. Effects of isoflurane on regional coronary blood flow and myocardial tissue pressure in chronically instrumented dogs. Anesthesiology (1994) 81:875–87.10.1097/00000542-199410000-000157943839
56. Crystal GJ, Khoury E, Gurevicious J, Salem MR. Direct effects of halothane on coronary blood flow, myocardial oxygen consumption, and myocardial segmental shortening in in situ canine hearts. Anesth Analg (1995) 80:256–62.10.1097/00000539-199502000-000107818110
57. Larach DR, Schuler GH. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology (1991) 75:268–78.10.1097/00000542-199108000-000151859014
58. Blaise GA, Noël J, Villeneuve E, Hollman C, Vinet B, Boulanger Y, et al. Effects of isoflurane, halothane, and enflurane on myocardial flow and energy stores in the perfused rat heart. Can J Physiol Pharmacol (1991) 69(6):752–60.10.1139/y91-1121913322
59. Gamperl AK, Hein TW, Kuo L, Cason BA. Isoflurane-induced dilation of porcine coronary microvessels is endothelium dependent and inhibited by glibenclamide. Anesthesiology (2002) 96:2465–71.10.1097/00000542-200206000-0002812170061
60. Cason B, Shubayev I, Hickey R. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation. Anesthesiology (1994) 81:1245–55.10.1097/00000542-199411000-000197978484
61. Zhou X, Abboud W, Manabat NC, Salem MR, Crystal GJ. Isoflurane-induced dilation of porcine coronary arterioles is mediated by ATP-sensitive potassium channels. Anesthesiology (1998) 89:182–9.10.1097/00000542-199807000-000259667308
62. Sarin SK, Sabba C, Groszmann RJ. Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. Am J Physiol (1990) 258:G365–9.2316651
63. Chance B, Williams GR, Hollunger G. Inhibition of electron and energy transfer in mitochondria. I. Effects of amytal, thiopental, rotenone, progresterone, and methylene glycol. J Biol Chem (1963) 278:418–31.
64. Bailey CJ, Flatt PR. Insulin and glucagon during pentobarbitone anaesthesia. Diabete Metabol (Paris) (1980) 6:91–5.
65. Durand JL, Hosinking W, Jelicks LA. Time course of effects of inhalation anesthesia on blood glucose level in male and female C57BL/6 mice. Horm Metab Res (2009) 41:339–41.10.1055/s-0028-1112114
66. Kass DA. Murine cardiac function: a cautionary tail. Circ Res (1998) 82:519–22.10.1161/01.RES.82.4.519
67. Janssen BJA, Smits JFM. Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol (2002) 282:R1545–64.10.1152/ajpregu.00714.200112010736
68. Georgakopoulos D, Kass D. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol (2001) 534(2):535–45.10.1111/j.1469-7793.2001.00535.x
69. Stull LB, Leppo MK, Marban E, Janssen PML. Physiological determinants of contractile force generation and calcium handling in mouse myocardium. J Mol Cell Cardiol (2002) 34:1367–76.10.1006/jmcc.2002.206512392997
70. Takimoto E, Soergel DG, Janssen PML, Stull LB, Kass DA, Murphy AM. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res (2004) 94:496–504.10.1161/01.RES.0000117307.57798.F514726477
71. Phillips D, Covian R, Aponte AM, Glancy B, Taylor JF, Chess D, et al. Regulation of oxidative phosphorylation complex activity: effects of tissue-specific metabolic stress within an allometric series and acute changes in workload. Am J Physiol Regul Integr Comp Physiol (2012) 302(9):R1034–48.10.1152/ajpregu.00596.201122378775
72. 2+. J Pharmacol Exp Ther (2011) 339:825–31.10.1124/jpet.111.18527221865439
73. Fukuto JM, Jackson MI, Kaludercic N, Paolocci N. Examining nitroxyl in biological systems. Methods Enzymol (2008) 440:411–31.10.1016/S0076-6879(07)00826-918423233
74. 2+ cycling. Circ Res (2007) 100:96–104.10.1161/01.RES.0000253904.53601.c917138943
75. Pacher P, Nagayama T, Mukhopadjyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc (2008) 3(9):1422–34.10.1038/nprot.2008.13818772869
76. Shioura K, Geenen DL, Goldspink PH. Sex-related changes in cardiac function following myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol (2008) 295:R528–34.10.1152/ajpregu.90342.200818550865
77. Joho S, Ishizaka D, Sievers R, Foster R, Simpson PC, Grossman W. Left ventricular pressure–volume relationship in conscious mice. Am J Physiol Heart Circ Physiol (2006) 292:H369–77.10.1152/ajpheart.00704.2006
78. Reyes M, Freeman GL, Escobedo D, Lee S, Steinhelper ME, Feldman MD. Enhancement of contractility with sustained afterload in the intact murine heart. Circulation (2003) 107:2962–8.10.1161/01.CIR.0000070964.96190.67
79. Yang B, Larson DF, Watson R. Age-related left ventricular function in the mouse: analysis based on in vivo pressure–volume relationships. Am J Physiol Heart Circ Physiol (1999) 277(5):H1906–13.
80. Georgakopoulos D, Mitzner W, Chen CH, Byrne BJ, Millar HD, Hare JM, et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol Heart Circ Physiol (1998) 274(43):H1416–22.9575947
81. Brunson DB. Pharmacology of inhalation anesthetics (chapter 3). 2nd ed. In: Fish RE, Brown MJ, Danneman PJ, Karas AZ, editors. Anesthesia and Analgesia in Laboratory Animals. London: Elsevier (2008). p. 83–93.
82. Price HL. Myocardial depression by nitrous oxide and its reversal by Ca++. Anesthesiology (1976) 44:211–5.10.1097/00000542-197603000-000091267888
83. Becker DE, Rosenberg M. Nitrous oxide and the inhalation anesthetics. Anesth Prog (2008) 55:124–31.10.2344/0003-3006-55.4.12419108597
84. Maze M, Fujinaga M. Recent advances in understanding the actions and toxicity of nitrous oxide. Anaesthesia (2000) 55:311–4.10.1046/j.1365-2044.2000.01463.x
85. Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide. Anesthesiology (2008) 109:707–22.10.1097/ALN.0b013e3181870a17
86. Pypendop BH, Ilkiw JE, Imai A, Bolich JA. Hemodynamic effects of nitrous oxide in isoflurane anesthetized cats. Vet Anaesth Analg (2002) 29(2):97–112.10.1046/j.1467-2995.2002.00078_5.x
87. Samarska IV, van Meurs M, Buikerma H, Houwertjes MC, Wulfert FM, Molema G, et al. Adjunct nitrous oxide normalizes vascular reactivity changes after hemorrhagic shock in mice under isoflurane anesthesia. Anesthesiology (2009) 111:600–8.10.1097/ALN.0b013e3181b31c8e19672168
88. Myles PS, Chan MTV, Kaye DM, McIIory DR, Lau CW, Symons JA, et al. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology (2008) 109:657–63.10.1097/ALN.0b013e31818629db18813045
89. Michaelides M, Georgiadou S, Constantinides C. In-vivo epicardial force and strain characterization in normal and MLP-knockout murine hearts. Physiol Meas (2015) 36(7):1573–90.10.1088/0967-3334/36/7/1573
90. Thireau J, Zhang BL, Poisson D, Babuty D. Heart rate variability in mice: a theoretical and practical guide. Exp Physiol (2007) 93(1):83–94.10.1113/expphysiol.2007.040733
91. Bernston GC, Bigger JT, Jr Eckberg DL, Grossman P, Kaufmann PG, Malik M, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology (1997) 34:623–48.10.1111/j.1469-8986.1997.tb02140.x9401419
92. Gerhmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CL. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol (2000) 279(2):H733–40.10924073
93. Hoit BD. Murine physiology: measuring the phenotype. J Mol Cell Cardiol (2004) 37:377–87.10.1016/j.yjmcc.2004.04.00515276007
94. Constantinides C, Mean R, Janssen BA. Heart rate and blood pressure variability effects as a result of oxygen and nitrous oxide administration in the anesthetized Mouse 2010. 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE-EMBS) ‘Merging Medical Humanism and Technology. Buenos Aires, Argentina (2010).
95. Manning WJ, Wei JY, Fossel ET, Burnstein D. Measurement of left ventricular mass in rats using electrocardiogram-gated magnetic resonance imaging. Am J Physiol (1990) 258:H1181–6.2331006
96. Shapiro EP. Evaluation of left ventricular hypertrophy by magnetic resonance imaging. Am J Card Imaging (1994) 8:310–5.7819725
97. Siri FM, Jelicks LA, Leinwand LA, Gardin JM. Gated magnetic resonance imaging of normal and hypertrophied murine hearts. Am J Physiol (1997) 272(41):H2394–402.9176310
98. Ruff J, Wiesmann F, Hiller KH, Voll S, von Kienlin M, Bauer WR, et al. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med (1998) 40:43–8.10.1002/mrm.19104001069660551
99. Slawson SE, Roman BB, Williams DS, Koretsky AP. Cardiac MRI of the normal and hypertrophied mouse heart. Magn Reson Med (1998) 39:980–7.10.1002/mrm.19103906169621922
100. Franco F, Dubois SK, Peshock RM, Shohet RV. Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy. Am J Physiol (1998) 274:H679–83.9486274
101. Wiesmann F, Ruff J, Haase A. High-resolution MR imaging in mice. MAGMA (1998) 6:186–8.10.1016/S1352-8661(98)00063-5
102. Wiesmann F, Frydrychowicz A, Rautenberg J, Illinger R, Rommel E, Haase A, et al. Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. Am J Physiol Heart Circ Physiol (2002) 283:H1065–71.10.1152/ajpheart.00802.200112181136
103. Schneider JE, Cassidy PJ, Lygate C, Tyler DJ, Wiesmann F, Grieve SM, et al. Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system. J Magn Reson Imaging (2003) 18:691–701.10.1002/jmri.1041114635154
104. Zhou R, Pickup S, Glickson JD, Scott CH, Ferrari VA. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magn Reson Med (2003) 49(4):760–4.10.1002/mrm.1042312652548
105. Epstein FH, Yang Z, Gilson WD, Berr SS, Kramer CM, French BA. MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn Reson Med (2002) 48(2):399–403.10.1002/mrm.1021012210951
106. Heijman E, Strijkers GJ, Habets J, Janssen B, Nicolay K. Magnetic resonance imaging of regional cardiac function in the mouse. MAGMA (2004) 17:170–8.10.1007/s10334-004-0082-415614514
107. Zhong X, Spottinswoode BS, Meyer CH, Kramer CM, Epstein FH. Imaging three dimensional myocardial mechanics using navigator-gated volumetric spiral cine DENSE MRI. Magn Reson Med (2010) 64(4):1089–97.10.1002/mrm.22503
108. van Heeswijk RB, Pilloud Y, Flogel U, Schwitter J, Stubber M. Fluorine-19 magnetic resonance angiography of the mouse. PLos One (2012) 7(7):e42236.10.1371/journal.pone.004223622848749
109. Xu Y, Tang P, Zhang W, Firestone L, Winter PM. Fluorine-19 nuclear magnetic resonance imaging and spectroscopy of sevoflurane uptake, distribution, and elimination in rat brain. Anesthesiology (1995) 83:766–74.10.1097/00000542-199510000-000167574056
110. Hemmings HC, Jr Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci (2005) 26(10):503–10.10.1016/j.tips.2005.08.00616126282
111. Kober F, Iltis I, Cozzone PJ, Bernard M. Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. MAGMA (2004) 17:157–61.10.1007/s10334-004-0086-015609036
112. Kofke WA, Hawkins RA, Davis DW, Biebuyck JF. Comparison of the effects of volatile anesthetics on brain glucose metabolism in rats. Anesthesiology (1987) 66:810–3.10.1097/00000542-198706000-000163592279
113. Larach DR, Schuler HG. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology (1991) 75(2):268–78.
114. Loeb AL, Raj NR, Longnecker DE. Cerebellar nitric oxide is increased during isoflurane anesthesia compared to halothane anesthesia. Anesthesiology (1998) 89:723–30.10.1097/00000542-199809000-00024
115. Tanelian DL, Kosek P, Mody I, Maciver B. The role of the GABAA receptor/chloride channel complex in anesthesia. Anesthesiology (1993) 78:757–76.10.1097/00000542-199304000-00020